AIBD

Here’s an opportunity for primary care to have a major impact on patients with a specialty-treated disease. Specialists will never boost vaccination rates to where they need to be. It’s just not what they do.

All patients with inflammatory bowel disease are at risk for anemia at any stage of their illness. In the past few years, there has been been increasing acceptance of the safety, efficacy, and speed of correcting deficiency with intravenous iron. Here: the pros and cons of oral vs IV supplementation.

These data suggest it may be worth a try-before moving on to potentially more dangerous drugs.

Fourteen state legislatures have passed legislation mandating that retail stores provide access to employee bathrooms for individuals with ulcerative colitis and Crohn disease and other medical needs.

Results are in on the maintenance phase of the TAXIT trial that employed infliXImab to treat patients with Crohn Disease and ulcerative colitis. Details here.

It's easy to mistake other serious gastrointestinal problems for inflammatory bowel disease. Here: clinical pearls that can help you recognize the IBD mimics.

This first report of effectiveness in a single case study should prompt additional research and placebo-controlled trials.

In case primary care physicians need another reason to pay attention to the overuse of antibiotics for nonbacterial illnesses.

Patients may be intimidated by their gastroenterologists, so it’ll probably fall on primary care to field them.

The Affordable Care Act comes none too soon for some of these patients.